News

Clovis, Genentech to test lung cancer combo


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Clovis, Genentech to test lung cancer combo


Date: 13/08/2015


Clovis Oncology and Roche’s Genentech have entered into a clinical trials pact to investigate whether two of their cancer therapies work better in tandem than alone.

The companies have drawn up plans to test a novel combination of Genentech's investigational PDL1 inhibitor atezolizumab (MPDL3280A) and Clovis’ rociletinib in advanced EGFR-mutant non-small cell lung cancer (NSCLC).

For more click here

Source: PharmaTimes

© Catalyst Innovation Portal 2019